Literature DB >> 15710248

Proteomics analysis of human astrocytes expressing the HIV protein Tat.

Chava B Pocernich1, Debra Boyd-Kimball, H Fai Poon, Visith Thongboonkerd, Bert C Lynn, Jon B Klein, Vittorio Calebrese, Avindra Nath, D Allan Butterfield.   

Abstract

Astrocyte infection in HIV has been associated with rapid progression of dementia in a subset of HIV/AIDS patients. Astrogliosis and microglial activation are observed in areas of axonal and dendritic damage in HIVD. In HIV-infected astrocytes, the regulatory gene tat is over expressed and mRNA levels for Tat are elevated in brain extracts from individuals with HIV-1 dementia. Tat can be detected in HIV-infected astrocytes in vivo. The HIV-1 protein Tat transactivates viral and cellular gene expression, is actively secreted mainly from astrocytes, microglia and macrophages, into the extracellular environment, and is taken up by neighboring uninfected cells such as neurons. The HIV-1 protein Tat released from astrocytes reportedly produces trimming of neurites, mitochondrial dysfunction and cell death in neurons, while protecting its host, the astrocyte. We utilized proteomics to investigate protein expression changes in human astrocytes intracellularly expressing Tat (SVGA-Tat). By coupling 2D fingerprinting and identification of proteins by mass spectrometry, we identified phosphatase 2A, isocitrate dehydrogenase, nuclear ribonucleoprotein A1, Rho GDP dissociation inhibitor alpha, beta-tubulin, crocalbin like protein/calumenin, and vimentin/alpha-tubulin to have decreased protein expression levels in SVGA-Tat cells compared to the SVGA-pcDNA cells. Heat shock protein 70, heme oxygenase-1, and inducible nitric oxide synthase were found to have increased protein expression in SVGA-Tat cells compared to controls by slotblot technique. These findings are discussed with reference to astrocytes serving as a reservoir for the HIV virus and how Tat promotes survival of the astrocytic host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710248     DOI: 10.1016/j.molbrainres.2004.10.023

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  18 in total

1.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

3.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

4.  Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations.

Authors:  Joseph R Berger; Malcolm Avison; Yunanan Mootoor; Carol Beach
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

5.  Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice.

Authors:  Elona Rrapo; Yuyan Zhu; Jun Tian; Huayan Hou; Adam Smith; Francisco Fernandez; Jun Tan; Brian Giunta
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

6.  First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.

Authors:  Li Zhou; Eve Diefenbach; Ben Crossett; Sieu L Tran; Thomas Ng; Helen Rizos; Rejane Rua; Bin Wang; Amit Kapur; Kaushal Gandhi; Bruce J Brew; Nitin K Saksena
Journal:  Mol Neurodegener       Date:  2010-06-24       Impact factor: 14.195

7.  Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production.

Authors:  Eric Y Chan; Wei-Jun Qian; Deborah L Diamond; Tao Liu; Marina A Gritsenko; Matthew E Monroe; David G Camp; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

8.  Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits.

Authors:  R L Self; K J Smith; T R Butler; J R Pauly; M A Prendergast
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

9.  Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

Review 10.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.